Top 4 NYSE Stocks In The Biotechnology Industry With The Highest ROE
Below are the top biotechnology stocks on the NYSE in terms of return on equity.
The trailing-twelve-month return on equity at ShangPharma Corporation (NYSE: SHP) is 13.44%. SHP's PEG ratio is 0.42.
The trailing-twelve-month return on equity at Medicis Pharmaceutical Corp (NYSE: MRX) is 12.43%. MRX's revenue for the same period is $716.57 million.
The trailing-twelve-month return on equity at Cambrex Corporation (NYSE: CBM) is 10.74%. CBM's PEG ratio is 0.92.
The trailing-twelve-month return on equity at Emergent Biosolutions Inc (NYSE: EBS) is 7.83%. EBS' operating margin for the same period is 17.41%.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Biotechnology Industry highest ROE NYSETrading Ideas
